PT  - JOURNAL ARTICLE
AU  - Lemech, Charlotte
AU  - Dredge, Keith
AU  - Bampton, Darryn
AU  - Hammond, Edward
AU  - Clouston, Andrew
AU  - Waterhouse, Nigel J
AU  - Stanley, Amanda C
AU  - Leveque-El Mouttie, Lucie
AU  - Chojnowski, Grace M
AU  - Haydon, Andrew
AU  - Pavlakis, Nick
AU  - Burge, Matthew
AU  - Brown, Michael P
AU  - Goldstein, David
TI  - Phase Ib open-label, multicenter study of pixatimod, an activator of TLR9, in combination with nivolumab in subjects with microsatellite-stable metastatic colorectal cancer, metastatic pancreatic ductal adenocarcinoma and other solid tumors
AID  - 10.1136/jitc-2022-006136
DP  - 2023 Jan 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e006136
VI  - 11
IP  - 1
4099  - http://jitc.bmj.com/content/11/1/e006136.short
4100  - http://jitc.bmj.com/content/11/1/e006136.full
SO  - J Immunother Cancer2023 Jan 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.